The following is a list of research publications citing use of Lifespan Technologies products, sorted by product.

Heparin Assay
Losada, A., Hoppensteadt, D., Litinas, E., Emanuele, J., Mostert, M., Linhardt, R., and Fareed, J. (2009) Bioavailability of Oversulfated Chondroitin Sulfate in Rats. Pharmacological Implications in Contaminated Heparins. FASEB J. 23, (Meeting Abstract Supplement) LB401

Ha, Y.-R., Oh, S.-R., Seo, E.-S., Kim, B.-H., Lee, D.-K., and Lee, S.-J. (2014) Detection of Heparin in the Salivary Gland and Midgut of Aedes togoi. The Korean Journal of Parasitology 52, 183–188. DOI: 10.1016/j.biomaterials.2010.05.022

Witt, R. M., Hecht, M.-L., Pazyra-Murphy, M. F., Cohen, S. M., Noti, C., van Kuppevelt, T. H., Fuller, M., Chan, J. A., Hopwood, J. J., Seeberger, P. H., and Segal, R. A. (2013) Heparan Sulfate Proteoglycans Containing a Glypican 5 Core and 2-O-Sulfo-iduronic Acid Function as Sonic Hedgehog Co-receptors to Promote Proliferation. Journal of Biological Chemistry 288, 26275–26288. DOI: 10.1074/jbc.M112.438937

Maaninka, K., Lappalainen, J., and Kovanen, P. T. (2013) Human Mast Cells Arise From a Common Circulating Progenito. Journal of Allergy and Clinical Immunology 132, 463–469.e3. DOI: 10.1016/j.jaci.2013.02.011

Bairstow, S., McKee, J., Nordhaus, M., and Johnson, R. (2009) Identification of a Simple and Sensitive Microplate Method for the Detection of Oversulfated Chondroitin Sulfate in Heparin Products. Analytical Biochemistry 388, 317–321. DOI: 10.1016/j.ab.2009.03.009

Bairstow, S. Methods and Assays For Oversulfated Glycosaminoglycans. Patent application no. 14/488534, filed September 17, 2014, Gurnee, IL.

Choi, Y. J., Lee, J. Y., Park, J. H., Park, J. B., Suh, J. S., Choi, Y. S., Lee, S. J., Chung, C.-P., and Park, Y. J. (2010) The Identification of a Heparin Binding Domain Peptide from Bone Morphogenetic Protein-4 and its Role on Osteogenesis. Biomaterials 31, 7226–7238. DOI: 10.1016/j.biomaterials.2010.05.022

Engelmaier, A., Zlabinger, C. and Weber, A., 2020. Establishment and Qualification of A Competitive Enzyme-Linked Immunosorbent Assay for the Measurement of Heparin in Plasma Products. Journal of Analytical Techniques and Research, 2(3), pp.110-112.

Lee, J.Y., Choo, J.E., Choi, Y.S., Lee, K.Y., Min, D.S., Pi, S.H., Seol, Y.J., Lee, S.J., Jo, I.H., Chung, C.P. and Park, Y.J., 2007. Characterization of the surface immobilized synthetic heparin binding domain derived from human fibroblast growth factor‐2 and its effect on osteoblast differentiation. Journal of Biomedical Materials Research Part A: An Official Journal of The Society for Biomaterials, The Japanese Society for Biomaterials, and The Australian Society for Biomaterials and the Korean Society for Biomaterials, 83(4), pp.970-979.

Leitgeb, A.M., Charunwatthana, P., Rueangveerayut, R., Uthaisin, C., Silamut, K., Chotivanich, K., Sila, P., Moll, K., Lee, S.J., Lindgren, M. and Holmer, E., 2017. Inhibition of merozoite invasion and transient de-sequestration by sevuparin in humans with Plasmodium falciparum malaria. PloS one, 12(12), p.e0188754.

Chan, B., Witt, N. and Choi, P.M., Article Title: Proteoglycan interactions with Sonic Hedgehog specify mitogenic responses.

Choi, S.H., Lee, J.Y., Suh, J.S., Park, Y.S., Chung, C.P. and Park, Y.J., 2016. Dual-function synthetic peptide derived from BMP4 for highly efficient tumor targeting and antiangiogenesis. International Journal of Nanomedicine, 11, p.4643.

Kayashima, Y., Clanton, C.A., Lewis, A.M., Sun, X., Hiller, S., Huynh, P., Wilder, J., Hagaman, J., Li, F., Maeda-Smithies, N. and Harris, E.N., 2022. Reduction of Stabilin-2 Contributes to a Protection Against Atherosclerosis. Frontiers in cardiovascular medicine, 9.

Witt, R.M., Hecht, M.L., Pazyra-Murphy, M.F., Cohen, S.M., Noti, C., Van Kuppevelt, T.H., Fuller, M., Chan, J.A., Hopwood, J.J., Seeberger, P.H. and Segal, R.A., 2013. Heparan Sulfate Proteoglycans Containing a Glypican 5 Core and 2-O-Sulfo-iduronic Acid Function as Sonic Hedgehog Co-receptors to Promote Proliferation*♦. Journal of Biological Chemistry, 288(36), pp.26275-26288.

Dextran Assay
Sriroth, K. (2013, January) Dextran Analysis in Thai Sugar Factories. Presented to Amano Enzyme Inc. and Cinnamon Company Limited.

Jonathon Marioneaux, Debbie Mayo, Mike Mostert, and Rebecca Caffrey A Novel Non-Lethal Technique for Serial Measurement of “Leaky Gut” And Relationship to NASH Liver Pathology in the DIAMOND™ Mouse Model Presented at AASLD 2018.

Rebecca Caffrey, PhD1; William Jo, PhD2; Nicole Deng, MS2; Madhavi Bhat, MS1, Jonathon Marioneaux, MS1 Methylnaltrexone and Rifaximin Treatments Significantly Improve Chronic “Leaky Gut” in a Diet-Induced Mouse Model of Nonalcoholic Fatty Liver Disease, presented at United European Gastroenterology (UEG) Week 2020 October 10-14, 2020, Amsterdam, The Netherlands. 1Sanyal Biotechnology LLC, Norfolk, VA, USA; 2Bausch Health Companies Inc., Bridgewater, NJ, USA

Stoeva, V., Rangelova, V. and Kondeva, V., Covid-19 among students and dental personnel in Dental Faculty, Plovdiv, Bulgaria. In Dear colleagues and friends, The present Supplement J. IMAB serves as a source for publications of papers, presented at the 11-th SEEC in a joint forum of 31-st Annual Assembly of IMAB, 28-31 October 2021, in Plovdiv, Bulgaria, and approved for a full-text presentation. The Supplement J. IMAB answers all criteria for a scientific journal, with every required by the (p. 27).

Dextran Sulfate Assay
Mundle, S. T., Hernandez, H., Hamberger, J., Catalan, J., Zhou, C., Stegalkina, S., Tiffany, A., Kleanthous, H., Delagrave, S., and Anderson, S. F. (2013) High-Purity Preparation of HSV-2 Vaccine Candidate ACAM529 Is Immunogenic and Efficacious In Vivo. PLoS ONE (Sawtell, N. M., Ed.) 8, e57224. DOI: 10.1371/journal.pone.0057224

Mundle, S. T., Anderson, S. F., and Delagrave, S. Purification of Herpes Virus. Patent application no. 14/369,844, filed September January 9, 2013, Cambridge, MA.

Dermatan Sulfate Assay
Liao, W.C., Liao, C.K., Tsai, Y.H., Tseng, T.J., Chuang, L.C., Lan, C.T., Chang, H.M. and Liu, C.H., 2018. DSE promotes aggressive glioma cell phenotypes by enhancing HB-EGF/ErbB signaling. PLoS One, 13(6), p.e0198364.